Use of Multiple Doses of Intravenous Infusion of Umbilical Cord-Mesenchymal Stem Cells for the Treatment of Adult Patients with Severe COVID-19-Related Acute Respiratory Distress Syndrome: Literature Review.
Stem cells international（2023）
摘要
According to our analysis, the ideal treatment dosage of IVF-UC-MSCs for severe COVID-19-induced ARDS is likely 5 × 10 cells/kg BW for three cycles within 5 days of ARDS onset in severe COVID-19 patients.
更多查看译文
关键词
acute respiratory distress syndrome,intravenous infusion,cord-mesenchymal
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要